Company profile: Exzell Pharma
1.1 - Company Overview
Company description
- Provider of medicines, healthcare and biopharma-based products, including EsopH OTC therapy for GERD that relieves heartburn and can be used with PPI prescriptions; Swiss Natural vitamins, supplements and minerals from natural sources; Salinex nasal spray to hydrate and cleanse; PediaVit vitamins and iron for infants and children; Koena multi-strain probiotics; and Ozonol ointment for scrapes, minor burns, and skin irritations.
Products and services
- Swiss Natural: Delivers natural-source formulated vitamins, mineral complexes, and dietary supplements for daily health maintenance and nutrient replenishment across varied needs
- EsopH: Over-the-counter therapy that relieves heartburn and acid reflux discomfort, and can be co-administered with a Proton Pump Inhibitor (PPI) prescription
- Koena: Multi-strain probiotic blend that supports digestive health by cultivating a favorable gut flora balance for routine gastrointestinal comfort and wellness
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Exzell Pharma
Rockwell Medical
HQ: United States
Website
- Description: Provider of hemodialysis concentrates (citric acid, acetic acid, bicarbonate) in liquid and powder forms; Triferic parenteral iron to maintain hemoglobin in adult patients with hemodialysis-dependent CKD; dry acid concentrate mixers for on-site preparation at dialysis clinics; and accessories such as cleaning agents, acetic acid cleaning solutions, citric acid descaling solutions, and filtration salts.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Rockwell Medical company profile →
SurfaceLogix
HQ: United States
Website
- Description: Provider of drug development leveraging biophysical chemistry to create new small molecule drugs with significantly improved pharmacokinetic and pharmacodynamic properties compared with class leaders.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full SurfaceLogix company profile →
Chiva Pharmaceuticals
HQ: United States
Website
- Description: Provider of global pharmaceutical solutions focused on bringing the best standard of care to the Chinese market and making drugs developed in China available worldwide.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Chiva Pharmaceuticals company profile →
4P Therapeutics
HQ: United States
Website
- Description: Provider of research and development of novel drug delivery technologies and therapeutics, developing pharmaceutical products from pre-clinical testing to clinical manufacturing, with a focus on meeting the needs of patients, physicians and payers.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full 4P Therapeutics company profile →
Valera Pharmaceuticals
HQ: United States
Website
- Description: Provider of specialty pharmaceutical services concentrating on development.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Valera Pharmaceuticals company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Exzell Pharma
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Exzell Pharma
2.2 - Growth funds investing in similar companies to Exzell Pharma
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Exzell Pharma
4.2 - Public trading comparable groups for Exzell Pharma
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →